Bayer Dealt Blow In Nexavar Feud With Cipla
In a setback for Bayer HealthCare AG, an Indian court has thrown out the German pharmaceutical giant's legal battle to stop Indian generics maker Cipla Ltd. from producing a copycat version...To view the full article, register now.
Already a subscriber? Click here to view full article